Avandia and diabetes patients have had a strained relationship since its release in 1999. A rosiglitazone drug, Avandia is manufactured by GlaxoSmithKline, and was developed for the treatment of type 2 diabetes by reducing insulin resistance in the body. Once the biggest selling diabetes drug in the world it was normally prescribed to taken in addition to other drugs such a metformin. According to a New York Times article, a study from 1999 to 2009 found more than 47,000 patients taking Avandia either suffered from a heart attack, stroke, heart failure, or death.

Avandia and Diabetes – Risk of Heart Attack

Numerous studies have been conducted on the increased risk of heart failure in patients who use Avandia. Numerous lawsuits have been filed against GlaxoSmithKline, resulting in the forced release of clinical studies on the drug. Following the studies release, Dr. Steven Nissen of the Cleveland Clinic began …